dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorFaculdade de Medicina de São José do Rio Preto (FAMERP)
dc.contributorUniversidade Federal do Pará (UFPA)
dc.contributorHemocentro
dc.date.accessioned2014-05-27T11:24:31Z
dc.date.accessioned2022-10-05T18:19:04Z
dc.date.available2014-05-27T11:24:31Z
dc.date.available2022-10-05T18:19:04Z
dc.date.created2014-05-27T11:24:31Z
dc.date.issued2009-12-01
dc.identifierGenetics and Molecular Research, v. 8, n. 4, p. 1345-1351, 2009.
dc.identifier1676-5680
dc.identifierhttp://hdl.handle.net/11449/71373
dc.identifier10.4238/vol8-4gmr662
dc.identifier2-s2.0-73449129014
dc.identifier2-s2.0-73449129014.pdf
dc.identifier3279428066176719
dc.identifier0000-0002-4603-9467
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3920562
dc.description.abstractGlucose-6-phosphate dehydrogenase (G6PD) deficiency is an enzymopathy in which reduced NADPH concentrations are not maintained, resulting in oxidative damage. We evaluated G6PD activity, oxidative stress levels and Trolox equivalent antioxidant capacity in individuals with the A-(202G>A) mutation for G6PD deficiency. Five hundred and forty-four peripheral blood samples were screened for G6PD deficiency; we also analyzed lipid peroxidation products measured as thiobarbituric acid reactive species and Trolox equivalent antioxidant capacity. Men with the A-(202G>A) mutation had lower G6PD activity than women with the same mutation. Individuals with the A-(202G>A) mutation also differed in mean Trolox equivalent antioxidant capacity values but not for thiobarbituric acid reactive species values. We concluded that A-(202G>A) mutation is associated with reduced G6PD activity and increased Trolox equivalent antioxidant capacity. ©FUNPEC-RP.
dc.languageeng
dc.relationGenetics and Molecular Research
dc.relation0,439
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectG6PD deficiency
dc.subjectOxidative stress
dc.subjectTBARS
dc.subjectTEAC
dc.subjectglucose 6 phosphate dehydrogenase
dc.subjectthiobarbituric acid reactive substance
dc.subjecttrolox C
dc.subjectadolescent
dc.subjectadult
dc.subjectaged
dc.subjectantioxidant activity
dc.subjectblood sampling
dc.subjectcolorimetry
dc.subjectcontrolled study
dc.subjectfemale
dc.subjectgene mutation
dc.subjectglucose 6 phosphate dehydrogenase deficiency
dc.subjecthuman
dc.subjectlipid peroxidation
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectoxidative stress
dc.subjectsex difference
dc.subjecttrolox equivalent antioxidant capacity
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAntioxidants
dc.subjectBase Sequence
dc.subjectDNA Primers
dc.subjectFemale
dc.subjectGlucosephosphate Dehydrogenase Deficiency
dc.subjectHumans
dc.subjectLipid Peroxidation
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectMutation
dc.subjectYoung Adult
dc.titleLipid peroxidation and antioxidant capacity of G6PD-deficient patients with A-(202G>A) mutation
dc.typeArtigo


Este ítem pertenece a la siguiente institución